Sculptor Capital LP GMED — GLOBUS MED INC

Ownership history in Sculptor Capital LP  ·  9 quarters on record

AI Ownership Summary

Sculptor Capital LP reported GLOBUS MED INC (GMED) in 9 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 2.94% in 2025 Q1. The latest visible filing shows GMED at 2.70% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this GMED ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Sculptor Capital LP's position in GLOBUS MED INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

GMED was reported at 2.70% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
2.94% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

GMED stock page Sculptor Capital LP fund profile Sculptor Capital LP full holdings
How Sculptor Capital LP held GMED — position size vs. price
% of Fund (quarterly)    GMED price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 14.3% -1.3% ✅ 3,000,000 -500,000 -14.3% 2.70% $261.9M 2026-02-13 $88.09
2025 Q3 ADDED — — — 3,500,000 +739,312 +26.8% 2.37% $200.4M 2025-11-14 $84.45
2025 Q2 ADDED — — — 2,760,688 +667,850 +31.9% 2.30% $162.9M 2025-08-14 $60.02
2025 Q1 ADDED — — — 2,092,838 +15,000 +0.7% 2.94% $153.2M 2025-05-15 $57.82
2024 Q4 REDUCED 6.0% -11.5% ✅ 2,077,838 -132,900 -6.0% 2.29% $171.9M 2025-02-14 $83.93
2024 Q3 UNCHANGED — — — 2,210,738 — 0% 2.69% $158.16B 2024-11-14 $81.10
2024 Q2 UNCHANGED — — — 2,210,738 — 0% 2.85% $151.41B 2024-08-14 $67.08
2024 Q1 ADDED — — — 2,210,738 +1,484,000 +204.2% 2.31% $118.58B 2024-05-15 $64.53
2023 Q4 INITIATED — — — 726,738 — — 0.82% $38.73B 2024-02-14 $52.75

🏢 Other funds also holding GMED

As of 2026 Q1 — sorted by position size

Paradice Investment Management LLC 3Y 7Y 7.95% TERRIL BROTHERS, INC. 3Y 7Y 7.57% Hyperion Capital Advisors LP 3Y 5.84% Pembroke Management, LTD 3Y 7Y 5.09% Varenne Capital Partners 3Y 4.95% Lightrock Netherlands B.V. 4.74% Foresight Group Ltd Liability Partnership 4.47% Defilade Capital Management, L.P. 4.29% Parsifal Capital Management, LP 3Y 3.93% SIRIOS CAPITAL MANAGEMENT L P 3Y 7Y 3.7%

FAQ About Sculptor Capital LP and GMED

These are the practical questions this page is built to answer before you even open the full history table.

How long has Sculptor Capital LP reported owning GMED?

Sculptor Capital LP reported GMED across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported GMED position in Sculptor Capital LP's portfolio?

The largest reported portfolio weight for GMED was 2.94% in 2025 Q1.

What is the latest reported GMED position on this page?

The most recent filing on this page is 2025 Q4, when Sculptor Capital LP reported 3,000,000 shares, equal to 2.70% of portfolio, with an estimated market value of $261.9M.

What does the chart on this GMED ownership page compare?

The chart compares Sculptor Capital LP's quarterly GMED portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Sculptor Capital LP time their GMED position?

Based on 13F filing dates vs. subsequent GMED price moves, Sculptor Capital LP correctly timed 6 out of 6 reported position changes (100%). The annualised alpha on GMED relative to SPY over the holding period was +9.2%.

← Back to Sculptor Capital LP Holdings